C.H. Robinson Worldwide, Inc.

The reported figures show a company whose revenue has contracted from its 2022 peak of $24.7 billion to $16.23 billion in 2025, while its profit lines have moved in the opposite direction. Operating income rose in each of the last two years, from $514.61 million in 2023 to $669.14 million in 2024 and $794.96 million in 2025, and operating margin rose from about 2.9% to about 4.9% over the same span. Net income climbed from $325.13 million in 2023 to $587.08 million in 2025, an increase of about 80.6%. Revenue was essentially flat in 2024, rising about 0.7% from $17.6 billion. Because no MD&A text, risk-factor text, or classified news headlines are on file, this analysis cannot name the segments, pricing, volume, or cost factors behind these results, and it cannot test management's explanation against the numbers. No forensic scores are on file. The Beneish M-Score, a screen for patterns that sometimes accompany earnings manipulation, is not available, so no screening conclusion can be drawn. The Piotroski F-Score, the Altman Z-Score, and the Fog Index are also absent, so this analysis gives no value or reading for any of them. Readers who want those screens should check the company's filings directly or a source that computes them from the same documents. Readers may also want to look at the 10-K for management's discussion of why revenue fell while operating income rose, and at the risk factors section for disclosed exposures.

Catalyst.The data set contains no MD&A text, so it offers no management explanation for 2025. The reported figures show revenue of $16.23 billion in 2025, down from $17.72 billion in 2024, a decline of about 8.4%. Over the same period operating income rose from $669.14 million to $794.96 million, an increase of about 18.8%, and net income rose from $465.69 million to $587.08 million, an increase of about 26.1%. Operating margin, which is operating income divided by revenue, was about 4.9% in 2025 compared with about 3.8% in 2024. Readers may want to look at the MD&A section of the 10-K for management's account of what drove these changes.

Hidden risk.Revenue has fallen from a $24.7 billion peak in 2022 to $16.23 billion in 2025, and operating income in 2025 of $794.96 million is still well below the $1.27 billion reported for 2022. The profit improvement is therefore measured on a smaller revenue base, and a reader cannot tell from these figures whether it reflects pricing, mix, cost control, or other factors because no risk-factor or MD&A text is on file. No forensic scores are on file either, so no manipulation or distress screen is available for this company. That absence is not a clean result, and readers may want to check the company's filings directly.